These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 22007939)
1. Epidermal growth factor receptor 1 expression is upregulated in undifferentiated thyroid carcinomas in humans. Landriscina M; Pannone G; Piscazzi A; Toti P; Fabiano A; Tortorella S; Occhini R; Ambrosi A; Bufo P; Cignarelli M Thyroid; 2011 Nov; 21(11):1227-34. PubMed ID: 22007939 [TBL] [Abstract][Full Text] [Related]
2. The role of survivin in thyroid tumors: differences of expression in well-differentiated, non-well-differentiated, and anaplastic thyroid cancers. Pannone G; Santoro A; Pasquali D; Zamparese R; Mattoni M; Russo G; Landriscina M; Piscazzi A; Toti P; Cignarelli M; Lo Muzio L; Bufo P Thyroid; 2014 Mar; 24(3):511-9. PubMed ID: 24117205 [TBL] [Abstract][Full Text] [Related]
3. Targeting epidermal growth factor receptor 1 signaling in human thyroid-stimulating hormone-independent thyroid carcinoma FRO cells results in a more chemosensitive and less angiogenic phenotype. Landriscina M; Piscazzi A; Fabiano A; Maddalena F; Costantino E; Farese A; Bufo P; Cignarelli M Thyroid; 2009 Jun; 19(6):629-37. PubMed ID: 19499990 [TBL] [Abstract][Full Text] [Related]
4. Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas. Chernock RD; El-Mofty SK; Becker N; Lewis JS Am J Surg Pathol; 2013 Aug; 37(8):1215-22. PubMed ID: 23681073 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of a hobnail pattern in papillary, poorly differentiated, and anaplastic thyroid carcinoma: a possible manifestation of high-grade transformation. Amacher AM; Goyal B; Lewis JS; El-Mofty SK; Chernock RD Am J Surg Pathol; 2015 Feb; 39(2):260-5. PubMed ID: 25321328 [TBL] [Abstract][Full Text] [Related]
6. Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma. Nikitski AV; Rominski SL; Condello V; Kaya C; Wankhede M; Panebianco F; Yang H; Altschuler DL; Nikiforov YE Thyroid; 2019 Oct; 29(10):1425-1437. PubMed ID: 31298630 [No Abstract] [Full Text] [Related]
7. Does the epidermal growth factor receptor play a role in the progression of thyroid cancer? Knauf JA Thyroid; 2011 Nov; 21(11):1171-4. PubMed ID: 22050034 [No Abstract] [Full Text] [Related]
8. Tight junctions in thyroid carcinogenesis: diverse expression of claudin-1, claudin-4, claudin-7 and occludin in thyroid neoplasms. Tzelepi VN; Tsamandas AC; Vlotinou HD; Vagianos CE; Scopa CD Mod Pathol; 2008 Jan; 21(1):22-30. PubMed ID: 17962811 [TBL] [Abstract][Full Text] [Related]
9. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. Nikiforova MN; Kimura ET; Gandhi M; Biddinger PW; Knauf JA; Basolo F; Zhu Z; Giannini R; Salvatore G; Fusco A; Santoro M; Fagin JA; Nikiforov YE J Clin Endocrinol Metab; 2003 Nov; 88(11):5399-404. PubMed ID: 14602780 [TBL] [Abstract][Full Text] [Related]
11. Metastatic thyroid carcinoma without identifiable primary tumor within the thyroid gland: a retrospective study of a rare phenomenon. Xu B; Scognamiglio T; Cohen PR; Prasad ML; Hasanovic A; Tuttle RM; Katabi N; Ghossein RA Hum Pathol; 2017 Jul; 65():133-139. PubMed ID: 28552827 [TBL] [Abstract][Full Text] [Related]
12. Pleiotropic effects of thyroid stimulating hormone in a differentiated thyroid cancer cell line. Studies on proliferation, thyroglobulin secretion, adhesion, migration and invasion. Zielke A; Hoffmann S; Plaul U; Duh QY; Clark OH; Rothmund M Exp Clin Endocrinol Diabetes; 1999; 107(6):361-9. PubMed ID: 10543413 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of epidermal growth factor receptor and its downstream effector, focal adhesion kinase, correlates with papillary thyroid carcinoma progression. Šelemetjev S; Bartolome A; Išić Denčić T; Đorić I; Paunović I; Tatić S; Cvejić D Int J Exp Pathol; 2018 Apr; 99(2):87-94. PubMed ID: 29665129 [TBL] [Abstract][Full Text] [Related]
14. Predictive Value of Sphingosine Kinase 1 Expression in Papillary Thyroid Carcinoma. Do SI; Kim HS; Kim K; Lee H; Do IG; Kim DH; Chae SW; Sohn JH Anticancer Res; 2017 Oct; 37(10):5399-5405. PubMed ID: 28982849 [TBL] [Abstract][Full Text] [Related]
15. Biological significance of aminopeptidase N/CD13 in thyroid carcinomas. Kehlen A; Lendeckel U; Dralle H; Langner J; Hoang-Vu C Cancer Res; 2003 Dec; 63(23):8500-6. PubMed ID: 14679016 [TBL] [Abstract][Full Text] [Related]
16. Syndecan-1 expression in thyroid carcinoma: stromal expression followed by epithelial expression is significantly correlated with dedifferentiation. Ito Y; Yoshida H; Nakano K; Takamura Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Matsuura N; Kuma K; Miyauchi A Histopathology; 2003 Aug; 43(2):157-64. PubMed ID: 12877731 [TBL] [Abstract][Full Text] [Related]
17. Serum levels of sex hormones and expression of their receptors in thyroid tissue in female patients with various types of thyroid neoplasms. Liu J; Chen G; Meng XY; Liu ZH; Dong S Pathol Res Pract; 2014 Dec; 210(12):830-5. PubMed ID: 25305147 [TBL] [Abstract][Full Text] [Related]
18. Receptors for epidermal growth factor and thyrotropin in thyroid carcinoma. Mäkinen T; Pekonen F; Franssila K; Lamberg BA Acta Endocrinol (Copenh); 1988 Jan; 117(1):45-50. PubMed ID: 3381624 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic role of HBME-1, galectin-3, and β-catenin in poorly differentiated and anaplastic thyroid carcinomas. Rossi ED; Straccia P; Palumbo M; Stigliano E; Revelli L; Lombardi CP; Santeusanio G; Pontecorvi A; Fadda G Appl Immunohistochem Mol Morphol; 2013 May; 21(3):237-41. PubMed ID: 23235344 [TBL] [Abstract][Full Text] [Related]
20. Expression profile of biomarkers altered in papillary and anaplastic thyroid carcinoma: Contribution of Tunisian patients. Fourati A; El Amine O; Ben Ayoub W; Cherni I; Goucha A; El May MV; Gamoudi A; El May A Bull Cancer; 2017 May; 104(5):433-441. PubMed ID: 28185633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]